Show simple item record

dc.contributor.authorMCCANN, SHAUN
dc.date.accessioned2009-10-28T15:48:15Z
dc.date.available2009-10-28T15:48:15Z
dc.date.issued2008
dc.date.submitted2008en
dc.identifier.citationAmjad Hayat, Shaun R. McCann, Stephen Langabeer, Sandra Irvine, Mary Frances McMullin, Eibhlin Conneally `Effective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantation? in Haematologica, 94, (2), 2008, pp 296-298en
dc.identifier.otherY
dc.identifier.other62009
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.format.extent296-298en
dc.format.extent251343 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.publisherFerrata Storti Foundationen
dc.relation.ispartofseriesHaematologicaen
dc.relation.ispartofseries94en
dc.relation.ispartofseries2en
dc.rightsYen
dc.subjectAdministrative Staff Authorsen
dc.titleEffective use of imatinib-mesylate in the treatment of relapsed chronic myeloid leukemia after allogeneic transplantationen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/srmccann
dc.identifier.rssurihttp://dx.doi.org/10.3324/haematol.13353
dc.identifier.urihttp://hdl.handle.net/2262/34395


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record